Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Theratome Bio Inc
Theratome Bio develops AI-enhanced, cell-free regenerative biologics to preserve tissues and treat ocular and ischemic injuries. The company produces second-generation secretomes—secreted factors…
Theratome Bio Inc
Theratome Bio develops AI-enhanced, cell-free regenerative biologics to preserve tissues and treat ocular and ischemic injuries. The company produces second-generation secretomes—secreted factors…
TL;DR
Stage: Development-stage therapeutics company
Focus: AI-enhanced, cell-free regenerative biologics (secretomes) for organ preservation and ocular/ischemic injuries
Founded: 2011
Headquarters: Gainesville, Florida
Notable investor: Texas HALO Fund (lead in Series A listed Oct 17, 2018)
Company Overview
Problem Domain
Organ transplant preservation; ocular disease (dry eye); ischemic and acute organ injuries
Founded
2011
Industry
Biotechnology
Tech Stack
Funding Track Record
Crunchbase lists a Series A round announced Oct 17, 2018 with Texas HALO Fund identified as lead investor
Investor Signal
“Texas HALO Fund led Series A (Oct 17, 2018)”